Peripheral blood gene expression as a novel genomic biomarker in complicated sarcoidosis.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Original Publication: San Francisco, CA : Public Library of Science

Gene Expression Regulation*; Biomarkers/*metabolism ; Sarcoidosis/*blood ; Sarcoidosis/*genetics; Adult ; Case-Control Studies ; Female ; Gene Expression Profiling ; Genetic Predisposition to Disease ; Genome-Wide Association Study ; Genomics ; Humans ; Male ; Middle Aged ; Models, Biological ; Oligonucleotide Array Sequence Analysis ; Receptors, Antigen, T-Cell/metabolism ; Signal Transduction

Sarcoidosis, a systemic granulomatous syndrome invariably affecting the lung, typically spontaneously remits but in ~20% of cases progresses with severe lung dysfunction or cardiac and neurologic involvement (complicated sarcoidosis). Unfortunately, current biomarkers fail to distinguish patients with remitting (uncomplicated) sarcoidosis from other fibrotic lung disorders, and fail to identify individuals at risk for complicated sarcoidosis. We utilized genome-wide peripheral blood gene expression analysis to identify a 20-gene sarcoidosis biomarker signature distinguishing sarcoidosis (n = 39) from healthy controls (n = 35, 86% classification accuracy) and which served as a molecular signature for complicated sarcoidosis (n = 17). As aberrancies in T cell receptor (TCR) signaling, JAK-STAT (JS) signaling, and cytokine-cytokine receptor (CCR) signaling are implicated in sarcoidosis pathogenesis, a 31-gene signature comprised of T cell signaling pathway genes associated with sarcoidosis (TCR/JS/CCR) was compared to the unbiased 20-gene biomarker signature but proved inferior in prediction accuracy in distinguishing complicated from uncomplicated sarcoidosis. Additional validation strategies included significant association of single nucleotide polymorphisms (SNPs) in signature genes with sarcoidosis susceptibility and severity (unbiased signature genes - CX3CR1, FKBP1A, NOG, RBM12B, SENS3, TSHZ2; T cell/JAK-STAT pathway genes such as AKT3, CBLB, DLG1, IFNG, IL2RA, IL7R, ITK, JUN, MALT1, NFATC2, PLCG1, SPRED1). In summary, this validated peripheral blood molecular gene signature appears to be a valuable biomarker in identifying cases with sarcoidoisis and predicting risk for complicated sarcoidosis.

BMC Bioinformatics. 2006 Apr 10;7:197. (PMID: 16606446)
N Engl J Med. 1997 Apr 24;336(17):1224-34. (PMID: 9110911)
Nat Protoc. 2009;4(1):44-57. (PMID: 19131956)
Nat Genet. 2007 Oct;39(10):1217-24. (PMID: 17873874)
Science. 2007 Feb 9;315(5813):848-53. (PMID: 17289997)
Chest. 2006 Jun;129(6):1584-91. (PMID: 16778279)
PLoS One. 2010 Feb 05;5(2):e9088. (PMID: 20140091)
Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5116-21. (PMID: 11309499)
Biochem Biophys Res Commun. 1994 Jan 14;198(1):25-31. (PMID: 8292028)
Semin Respir Crit Care Med. 2010 Aug;31(4):428-41. (PMID: 20665393)
Am J Hum Genet. 2008 May;82(5):1101-13. (PMID: 18439551)
Am J Respir Crit Care Med. 1996 Feb;153(2):851-4. (PMID: 8564143)
Cell Regul. 1990 Oct;1(11):811-9. (PMID: 2088527)
Chest. 2003 May;123(5):1520-6. (PMID: 12740269)
QJM. 1999 Feb;92(2):103-17. (PMID: 10209662)
Ann N Y Acad Sci. 1976;278:69-79. (PMID: 786127)
Am J Hum Genet. 2003 Oct;73(4):720-35. (PMID: 14508706)
J Clin Oncol. 2006 Apr 20;24(12):1839-45. (PMID: 16622258)
Nat Genet. 2005 Apr;37(4):357-64. (PMID: 15735647)
Am J Respir Crit Care Med. 2003 Nov 15;168(10):1162-6. (PMID: 12882757)
Arthritis Res Ther. 2009;11(6):R168. (PMID: 19900269)
Chest. 2011 Jan;139(1):174-82. (PMID: 21208877)
Nature. 2004 Aug 12;430(7001):743-7. (PMID: 15269782)
Eur J Hum Genet. 2000 Sep;8(9):717-20. (PMID: 10980579)
Am J Respir Crit Care Med. 2005 Nov 15;172(10):1299-307. (PMID: 16100009)
Am J Hum Genet. 2008 Mar;82(3):631-40. (PMID: 18313023)
Am J Respir Crit Care Med. 1999 Aug;160(2):736-55. (PMID: 10430755)
Hum Genet. 2004 Apr;114(5):503-9. (PMID: 15004750)
Am J Respir Crit Care Med. 2002 Jan 15;165(2):148-51. (PMID: 11790645)
Nat Genet. 2007 Feb;39(2):226-31. (PMID: 17206142)
Am J Respir Crit Care Med. 2010 Jun 15;181(12):1367-75. (PMID: 20194811)
J Cell Biol. 1993 Aug;122(4):933-40. (PMID: 8349739)
Proc Am Thorac Soc. 2007 Jan;4(1):108-16. (PMID: 17202299)
Am J Respir Cell Mol Biol. 2000 Jun;22(6):672-5. (PMID: 10837363)
Am J Respir Crit Care Med. 2004 Mar 15;169(6):696-702. (PMID: 14656748)
Clin Exp Immunol. 1977 Feb;27(2):227-9. (PMID: 849654)
Genome Biol. 2003;4(5):P3. (PMID: 12734009)
Exp Eye Res. 1994 Dec;59(6):665-78. (PMID: 7698260)
Proc Natl Acad Sci U S A. 2002 May 14;99(10):6567-72. (PMID: 12011421)
Am J Respir Crit Care Med. 2001 Sep 1;164(5):840-6. (PMID: 11549543)
Am J Respir Crit Care Med. 2011 Nov 15;184(10):1153-63. (PMID: 21852540)
Am J Respir Crit Care Med. 2001 Jul 15;164(2):197-201. (PMID: 11463587)
Thorax. 1996 Aug;51(8):777-80. (PMID: 8795663)
Proc Natl Acad Sci U S A. 1993 May 1;90(9):3889-93. (PMID: 8483908)
Proc Am Thorac Soc. 2007 Aug 15;4(5):461-4. (PMID: 17684290)
Chest. 2006 Oct;130(4):982-8. (PMID: 17035428)
J Clin Invest. 1995 Aug;96(2):1018-25. (PMID: 7635938)
N Engl J Med. 2007 Nov 22;357(21):2153-65. (PMID: 18032765)
Eur J Hum Genet. 2002 Nov;10(11):729-32. (PMID: 12404105)
Nucleic Acids Res. 2004 Jan 1;32(Database issue):D277-80. (PMID: 14681412)
Am J Respir Crit Care Med. 2005 May 15;171(10):1136-41. (PMID: 15750046)
Hepatology. 1995 Nov;22(5):1584-90. (PMID: 7590679)
J Invest Dermatol. 1996 Jan;106(1):49-56. (PMID: 8592081)
Clin Exp Immunol. 2006 Mar;143(3):420-6. (PMID: 16487240)

U01 HL105371 United States HL NHLBI NIH HHS; HL68019 United States HL NHLBI NIH HHS; K23 HL098454 United States HL NHLBI NIH HHS; RC2 HL101740-01 United States HL NHLBI NIH HHS; U01HL105371-01 United States HL NHLBI NIH HHS; R01 HL068019 United States HL NHLBI NIH HHS; NHLBI K23HL098454 United States PHS HHS; R01HL112051 United States HL NHLBI NIH HHS; HL83870 United States HL NHLBI NIH HHS; RC2 HL101740 United States HL NHLBI NIH HHS; NHLBI HL58094 United States PHS HHS; R01 HL083870 United States HL NHLBI NIH HHS

0 (Biomarkers)
0 (Receptors, Antigen, T-Cell)

Date Created: 20120918 Date Completed: 20130312 Latest Revision: 20211021

20221213

PMC3440319

10.1371/journal.pone.0044818

22984568